BFM
LJPC

Boothbay Fund Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Boothbay Fund Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20,620
Closed -$88K – 1390
2020
Q2 		$88K Buy
20,620
+2,220
+12% +$13.5K 0.01% 891
2020
Q1 		$77K Buy
+18,400
New +$116K 0.01% 756
2019
Q3 		– Sell
-74,835
Closed -$692K – 1026
2019
Q2 		$692K Buy
+74,835
New +$564K 0.06% 351

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Boothbay Fund Management's LJPC Position: Q3 2020 in Review

Boothbay Fund Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2020, closing a stake of 20,620 shares — an estimated $88K sold.

Boothbay Fund Management first reported a position in LJPC in Q2 2019 and held it in 3 quarters. The position peaked at $692K in Q2 2019. 64 funds tracked by Wall St. Rank hold LJPC as of Q3 2020.

  • Boothbay Fund Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 20,620 La Jolla Pharmaceutical Company shares in Q3 2020, an estimated $88K.
  • Boothbay Fund Management first reported a position in La Jolla Pharmaceutical Company in Q2 2019 and held it in 3 quarters.
  • Boothbay Fund Management's La Jolla Pharmaceutical Company position peaked at $692K in Q2 2019.
  • 64 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2020.

Based on Boothbay Fund Management's 13F filing for Q3 2020, filed 16 Nov 2020.